We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

011780:KRXKumho Petrochemical Co., Ltd. Analysis

Data as of 2026-03-15 - not real-time

₩116,300.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kumho Petro Chemical trades at 116,300 KRW, well below its DCF‑derived fair value of roughly 220,500 KRW, implying a sizable upside. The forward PE of 6.47 and a dividend yield of 1.46 % with a modest payout ratio (~16 %) suggest the stock is attractively priced relative to earnings. Technicals show a 20‑day SMA of 135,940 KRW and a 50‑day SMA of 135,380 KRW, both above the current price, indicating short‑term pressure but also room for a bounce. RSI sits at 35, signaling oversold conditions that could precede a corrective rally. MACD remains bearish, with the histogram at –2,860, hinting that momentum is still negative in the near term. Volume trend is increasing, supporting the potential for price appreciation as buying interest builds.
Fundamental metrics reveal a low ROE of 5.7 % and a high debt‑to‑equity ratio of 16.36, underscoring the need for careful monitoring of leverage. Nevertheless, the company generates strong operating cash flow (≈753 billion KRW) and free cash flow (≈416 billion KRW), providing a solid cushion for dividend payments. The sector—specialty chemicals—carries medium cyclicality risk, yet Kumho’s diversified product mix and cogeneration assets add resilience. Analyst consensus is “strong buy” with a median target of 157,500 KRW, translating to an estimated 41 % upside. The market’s “greed” sentiment index stands at 72.9, indicating bullish sentiment that could further support price gains. Overall, the combination of undervaluation, dividend sustainability, and improving technicals makes the stock a compelling opportunity for investors willing to tolerate moderate volatility.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI indicating near‑term price rebound potential
  • Increasing volume supporting demand
  • Current price far below DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong analyst consensus with median target of 157,500 KRW
  • Sustainable dividend yield and low payout ratio
  • Undervalued relative to forward PE and DCF

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Diversified specialty‑chemical portfolio providing resilience
  • High leverage requiring monitoring
  • Long‑term upside to DCF fair value of ~220,500 KRW

Key Metrics & Analysis

Financial Health

Revenue Growth-10.10%
Profit Margin4.92%
P/E Ratio6.5
ROE5.75%
ROA2.10%
Debt/Equity16.36
Op. Cash Flow₩753.4B
Free Cash Flow₩415.9B

Technical Analysis

TrendBullish
RSI35.1
Support₩0.00
Resistance₩162,300.00
MA 20₩135,940.00
MA 50₩135,380.00
MA 200₩120,187.75
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value₩220,518.44
Target Price₩164,714.28
Upside/Downside41.63%
GradeUndervalued
TypeValue
Dividend Yield1.46%

Risk Assessment

Beta0.48
Volatility65.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.